Companies need to assess the best way to make technological investments in research and development (R&D) and supply chain that will be necessary for preparedness for the future while also delivering answers to current pressing demands. As part of this process priorities will need to be considered from alternative scenarios.
Many companies are seeking to implement change, based on today’s competitive challenges without taking into account the overall long term perspective, often concentrating efforts in one business area. This is because decisions are not being informed by a clear vision or a broadly evaluated business case. Such a vision must address the regulatory, market, scientific and technological forces that will shape pharmaceutical R&D and manufacturing in the future. The outcome of this type of process will be a view about what type of R&D and manufacturing strategy and plant the company needs in a more medium to long term timeframe, say five to ten years time which, in turn, can frame the steps they take now. The answer may be different from plant to plant and many companies are likely to need to plan for a mix of scenarios.
The technological change roadmap needs to be shaped by calculations based on a proper assessment of the future and how that influences the assumptions built into the decision making process; this then links to ROI (return on investment) or expected net present value (NPV) and risk evaluation ensuring a route to the future destinations as well as an effective answer to the more short to medium term five, ten and fifteen year challenges along the way.
How PwC's consultants can help you
PwC’s Information Technology services practice provides a full range of services, from quality by design (QbD), process analytical technology (PAT) solutions, product lifecycle to knowledge management tools.